![Abhinav Jain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abhinav Jain
Directeur/Membre du Conseil chez
AYTU BIOPHARMA, INC.
Fortune : 123 960 $ au 31/05/2026
Profil
Mr. Abhinav Jain is an Independent Director at Eagle Pharmaceuticals, Inc., an Independent Director at Talphera, Inc. and an Independent Director at Aytu Biopharma, Inc. He is on the Board of Directors at Eagle Pharmaceuticals, Inc., Xtant Medical Holdings, Inc., Talphera, Inc. and Aytu Biopharma, Inc. Mr. Jain was previously employed as an Associate by Angelo, Gordon & Co. LP.
He received his undergraduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/11/2025 | 158 228 ( 0,11 % ) | 73 101 $ | 31/05/2026 | |
AYTU BIOPHARMA, INC. 0,18 % | 13/10/2025 | 19 500 ( 0,18 % ) | 44 655 $ | 31/05/2026 |
TALPHERA, INC. 0,02 % | 24/04/2026 | 7 602 ( 0,02 % ) | 6 203 $ | 31/05/2026 |
Postes actifs de Abhinav Jain
| Sociétés | Poste | Début |
|---|---|---|
| AYTU BIOPHARMA, INC. | Directeur/Membre du Conseil | 12/06/2023 |
| TALPHERA, INC. | Directeur/Membre du Conseil | 22/01/2024 |
| XTANT MEDICAL HOLDINGS, INC. | Directeur/Membre du Conseil | 01/08/2025 |
| EAGLE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/08/2025 |
Anciens postes connus de Abhinav Jain
| Sociétés | Poste | Fin |
|---|---|---|
Angelo, Gordon & Co. LP
 Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Corporate Officer/Principal | 01/01/2017 |
Formation de Abhinav Jain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Angelo, Gordon & Co. LP
Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Xtant Medical Holdings, Inc.
 Xtant Medical Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and commercializes surgical products | Health Technology |
